Plasma P-tau217 has been associated with both amyloid and tau accumulation.33 The possible association with tau load in the brain is a potential reason why plasma P-tau217 performed better than other plasma biomarkers, but we do not know the extent to which high plasma P-tau217 in these preclinical AD cohorts was associated with tau PET uptake. Here, MAPT is linked to amyloidosis.